Granahan Investment Management LLC Decreases Stock Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

Granahan Investment Management LLC lessened its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS) by 22.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 786,369 shares of the company’s stock after selling 223,890 shares during the quarter. Granahan Investment Management LLC’s holdings in OrthoPediatrics were worth $18,228,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of KIDS. Wellington Management Group LLP increased its holdings in shares of OrthoPediatrics by 20.2% in the 4th quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock valued at $24,601,000 after acquiring an additional 178,078 shares during the last quarter. Wasatch Advisors LP increased its stake in OrthoPediatrics by 47.2% in the fourth quarter. Wasatch Advisors LP now owns 696,318 shares of the company’s stock valued at $16,141,000 after purchasing an additional 223,217 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in OrthoPediatrics by 29.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock worth $15,576,000 after purchasing an additional 152,681 shares in the last quarter. Harbor Capital Advisors Inc. lifted its position in shares of OrthoPediatrics by 1.9% during the 4th quarter. Harbor Capital Advisors Inc. now owns 251,588 shares of the company’s stock worth $5,832,000 after buying an additional 4,728 shares during the last quarter. Finally, Kennedy Capital Management LLC boosted its holdings in shares of OrthoPediatrics by 129.8% in the 4th quarter. Kennedy Capital Management LLC now owns 249,978 shares of the company’s stock valued at $5,794,000 after buying an additional 141,174 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on KIDS shares. Lake Street Capital started coverage on shares of OrthoPediatrics in a research note on Monday, April 7th. They set a “buy” rating and a $37.00 price target on the stock. Piper Sandler cut their target price on OrthoPediatrics from $40.00 to $30.00 and set an “overweight” rating on the stock in a research report on Thursday. Needham & Company LLC reissued a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a research report on Thursday. Stifel Nicolaus cut their price target on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a research report on Wednesday, March 5th. Finally, Truist Financial reduced their price objective on OrthoPediatrics from $26.00 to $24.00 and set a “hold” rating for the company in a research note on Friday, April 11th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, OrthoPediatrics has a consensus rating of “Moderate Buy” and an average price target of $35.83.

Insider Transactions at OrthoPediatrics

In other OrthoPediatrics news, insider Gregory A. Odle sold 5,359 shares of OrthoPediatrics stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $133,224.74. Following the sale, the insider now owns 148,788 shares of the company’s stock, valued at approximately $3,698,869.68. The trade was a 3.48 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Daniel J. Gerritzen sold 5,310 shares of the business’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $132,006.60. Following the transaction, the general counsel now owns 110,767 shares in the company, valued at $2,753,667.62. The trade was a 4.57 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 23,732 shares of company stock worth $589,978. Company insiders own 32.70% of the company’s stock.

OrthoPediatrics Stock Performance

Shares of KIDS stock opened at $22.04 on Friday. The stock’s 50-day moving average price is $23.08 and its 200 day moving average price is $24.09. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $535.29 million, a PE ratio of -17.92 and a beta of 1.09. OrthoPediatrics Corp. has a 52-week low of $20.25 and a 52-week high of $35.99.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Wednesday, May 7th. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.13). OrthoPediatrics had a negative return on equity of 5.78% and a negative net margin of 15.00%. The company had revenue of $52.41 million for the quarter, compared to analysts’ expectations of $51.68 million. As a group, equities research analysts forecast that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.